Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials

Beck, Roy W., Bergenstal, Richard M., Riddlesworth, Tonya D., Kollman, Craig, Li, Zhaomian, Brown, Adam S., Close, Kelly L.·2019·Diabetes Care
DOI 10.2337/dc18-1444

Cited by (792)

Items 101–200 of 792

  1. Associations between continuous glucose monitoring-derived metrics and diabetic retinopathy and albuminuria in patients with type 2 diabetes
    Satomi Wakasugi, Tomoya Mita, Naoto Katakami, Yosuke Okada, Hidenori Yoshii, Takeshi Osonoi, Keiko Nishida, Toshihiko Shiraiwa, Keiichi Torimoto, Akira Kurozumi et al. · 2021 · BMJ Open Diabetes Research & Care
  2. Dapagliflozin: A Review in Type 1 Diabetes
    Julia Paik, Hannah A. Blair · 2019 · Drugs
  3. Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
    Marc Evans, Debbie Hicks, Dipesh Patel, Vinod Patel, Phil C. McEwan, Umesh Kumar Dashora · 2019 · Diabetes Therapy
  4. Safety and glycemic outcomes of do-it-yourself AndroidAPS hybrid closed-loop system in adults with type 1 diabetes
    Andrzej Gawrecki, Dorota Zozulińska‐Ziółkiewicz, Magdalena Michalak, Anna Adamska, Michał Michalak, Urszula Frąckowiak, Justyna Flotyńska, Monika Pietrzak, Szymon Czapla, Bernhard Gehr et al. · 2021 · PLoS ONE
  5. Time-in-range for monitoring glucose control: Is it time for a change?
    Virginia Bellido, Pedro José Pinés-Corrales, Rocío Villar‐Taibo, Francisco Javier Ampudia‐Blasco · 2021 · Diabetes Research and Clinical Practice
  6. Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data
    Smadar Shilo, Anastasia Godneva, Marianna Rachmiel, Tal Korem, Dmitry S. Kolobkov, Tal Karady, Noam Bar, Bat Chen Wolf, Yitav Glantz-Gashai, Michal Cohen et al. · 2021 · Diabetes Care
  7. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy
    David Rodbard · 2022 · Diabetes Obesity and Metabolism
  8. Shaping Workflows in Digital and Remote Diabetes Care During the COVID-19 Pandemic via Service Design: Prospective, Longitudinal, Open-label Feasibility Trial
    Katarina Braune, Karina Boß, Jessica Schmidt-Herzel, Katarzyna Anna Gajewska, Axel Thieffry, Lilian Schulze, Barbara Posern, Klemens Raile · 2020 · JMIR mhealth and uhealth
  9. The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set
    Beck, Roy W., Bergenstal, Richard M., Riddlesworth, Tonya D., Kollman, Craig · 2019 · Diabetes Technology & Therapeutics
  10. Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring
    Michelle Diane Lundholm, Mary Ann Emanuele, Alina Ashraf, Sarah Nadeem · 2020 · Journal of Diabetes and its Complications
  11. Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases
    ABDULHALIM M. ALMURASHI, Erika Rodriguez, Satish K. Garg · 2023 · Journal of the Indian Institute of Science
  12. Feasibility of Real-Time Continuous Glucose Monitoring Telemetry System in an Inpatient Diabetes Unit: A Pilot Study
    Clémentine Dillmann, Lamia Amoura, Fatema Fall-Mostaine, Adrien Coste, Leila Bounyar, Laurence Kessler · 2021 · Journal of Diabetes Science and Technology
  13. In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial
    Thekla von dem Berge, K Remus, Sarah Biester, Felix Reschke, Britta Klusmeier, Kerstin Adolph, Anette Holtdirk, Andreas Thomas, Olga Kordonouri, Thomas Danne et al. · 2022 · Diabetes Obesity and Metabolism
  14. Time in range: How to measure it, how to report it, and its practical application in clinical decision-making
    Wright, Eugene E., Morgan, Kayla, Fu, Danny K., Wilkins, Nick, Guffey, William J. · 2020 · Clinical Diabetes
  15. Differences for percentage times in glycemic range between continuous glucose monitoring and capillary blood glucose monitoring in adults with type 1 diabetes: analysis of the REPLACE-BG dataset
    Avari, Parizad, Uduku, Chukwuma, George, Daniel, Herrero, Pau, Reddy, Monika, Oliver, Nick · 2020 · Diabetes Technology & Therapeutics
  16. A single-blind, randomised, crossover study to reduce hypoglycaemia risk during postprandial exercise with closed-loop insulin delivery in adults with type 1 diabetes: Announced (with or without bolus reduction) vs unannounced exercise strategies
    Tagougui, Sémah, Taleb, Nadine, Legault, Laurent, Suppère, Corinne, Messier, Virginie, Boukabous, Inès, Shohoudi, Azadeh, Ladouceur, Martin, Rabasa-Lhoret, Rémi · 2020 · Diabetologia
  17. Significance of Glycemic Variability in Diabetes Mellitus
    Kusunoki, Yoshiki, Konishi, Kosuke, Tsunoda, Taku, Koyama, Hidenori · 2022 · Internal Medicine
  18. Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
    Richard M. Bergenstal, ELISE HACHMANN-NIELSEN, Kajsa Kvist, Anne L. Peters, Jens M. Tarp, John B. Buse · 2023 · Diabetes Technology & Therapeutics
  19. The Association of Time in Range and Diabetic Complications: The Evidence Is Strong
    Roy W. Beck · 2023 · Diabetes Technology & Therapeutics
  20. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes
    Virginia Bellido, Eva Aguilera, Roque Cardona‐Hernandez, Gonzalo Díaz-Soto, Noemí González Pérez de Villar, María José Picón César, Francisco Javier Ampudia‐Blasco · 2022 · Journal of Diabetes Science and Technology
  21. Detection of Hypoglycemia and Hyperglycemia Using Noninvasive Wearable Sensors: Electrocardiograms and Accelerometry
    Darpit Dave, Kathan Vyas, Kimberly L. Branan, Siripoom Vudhipoom McKay, Daniel J. DeSalvo, Ricardo Gutiérrez‐Osuna, Gerard L. Coté, Madhav Erraguntla · 2022 · Journal of Diabetes Science and Technology
  22. Use of Continuous Glucose Monitors to Manage Type 1 Diabetes Mellitus: Progress, Challenges, and Recommendations
    Jared G. Friedman, Zulma Cardona, Emily Deborah Szmuilowicz, Grazia Aleppo · 2023 · Pharmacogenomics and Personalized Medicine
  23. Reconsidering the role of glycaemic control in cardiovascular disease risk in type 2 diabetes: A 21st century assessment
    Vanita R. Aroda, Robert H. Eckel · 2022 · Diabetes Obesity and Metabolism
  24. Reinforcement Learning Models and Algorithms for Diabetes Management
    Kok‐Lim Alvin Yau, Yung-Wey Chong, Xiumei Fan, Celimuge Wu, Yasir Saleem, Phei-Ching Lim · 2023 · IEEE Access
  25. The role of real‐time continuous glucose monitoring in diabetes management and how it should link to integrated personalized diabetes management
    Monika Reddy, Nick S. Oliver · 2024 · Diabetes Obesity and Metabolism
  26. Evaluating Glucose Control With a Novel Composite Continuous Glucose Monitoring Index
    Lalantha Leelarathna, Hood Thabit, Malgorzata E. Wilinska, Lia Bally, Julia Katharina Mader, Thomas Rudolf Pieber, Carsten Benesch, Sabine Arnolds, Terri Kang Johnson, Lutz Heinemann et al. · 2019 · Journal of Diabetes Science and Technology
  27. Sleep coach intervention for teens with type 1 diabetes: Randomized pilot study
    Sarah S. Jaser, Emily Hamburger, Erin M. Bergner, Rodayne Williams, James C. Slaughter, Jill H. Simmons, Beth Ann Malow · 2020 · Pediatric Diabetes
  28. Leveraging advances in diabetes technologies in primary care: a narrative review
    Bruce W. Bode, Aaron King, David L Russell-Jones, Liana K. Billings · 2021 · Annals of Medicine
  29. Clinical application guidelines for blood glucose monitoring in China (2022 edition)
    Y.-Z. Bao, Da-Long Zhu · 2022 · Diabetes/Metabolism Research Reviews
  30. C ontinuous glucose monitoring‐based time‐in‐range using insulin glargine 300 units/ ml versus insulin degludec 100 units/ ml in type 1 diabetes: The head‐to‐head randomized controlled InRange trial
    Tadej Battelino, Thomas Danne, Steven V. Edelman, Pratik Choudhary, Éric Renard, Jukka Westerbacka, Bhaswati Mukherjee, Valérie Pilorget, Mathieu Coudert, Richard M. Bergenstal · 2022 · Diabetes Obesity and Metabolism
  31. Time in tight range: A key metric for optimal glucose control in the era of advanced diabetes technologies and therapeutics
    Ziyi Zhang, Yaxin Wang, Jingyi Lu, Jian Zhou · 2024 · Diabetes Obesity and Metabolism
  32. Comparison of Multiple Cut Points for Time in Range in Relation to Risk of Abnormal Carotid Intima-Media Thickness and Diabetic Retinopathy
    Jingyi Lu, Philip D. Home, Jian Zhou · 2020 · Diabetes Care
  33. Evaluation of Reference Metrics for Continuous Glucose Monitoring in Persons Without Diabetes and Prediabetes
    Sheyda Sofizadeh, Anders Pehrsson, Arndís Finna Ólafsdóttir, Marcus Lind · 2020 · Journal of Diabetes Science and Technology
  34. Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta‐analysis of randomized controlled trials
    Lu, Jiaping, Ying, Zhen, Wang, Ping, Fu, Minjie, Han, Chenyu, Zhang, Min · 2024 · Diabetes, Obesity and Metabolism
  35. The Virtual DCCT: Adding Continuous Glucose Monitoring to a Landmark Clinical Trial for Prediction of Microvascular Complications
    Boris P. Kovatchev, Benjamin J. Lobo, Chiara Fabris, Mohammadreza Ganji, Anas El Fathi, Marc D. Breton, Lauren G. Kanapka, Craig Kollman, Tadej Battelino, Roy W. Beck · 2025 · Diabetes Technology & Therapeutics
  36. Effect of Exercise and Meals on Continuous Glucose Monitor Data in Healthy Individuals Without Diabetes
    Stephanie N. DuBose, Zoey Li, Jennifer L. Sherr, Roy W. Beck, William V. Tamborlane, Viral N. Shah · 2020 · Journal of Diabetes Science and Technology
  37. A higher non-severe hypoglycaemia rate is associated with an increased risk of subsequent severe hypoglycaemia and major adverse cardiovascular events in individuals with type 2 diabetes in the LEADER study
    Simon R. Heller, Milan S. Geybels, Ahmed Iqbal, Lei Liu, Lily Wagner, Elaine Chow · 2021 · Diabetologia
  38. Ambulatory Glucose Profile (AGP) Report in Daily Care of Patients with Diabetes: Practical Tips and Recommendations
    Leszek Czupryniak, Grzegorz Jan Dzida, Piotr Fichna, Przemysława A. Jarosz-Chobot, Janusz Gumprecht, Tomasz Klupa, Małgorzata Myśliwiec, Agnieszka Szadkowska, Dorota Agata Bomba-Opon, Krzysztof Czajkowski et al. · 2022 · Diabetes Therapy
  39. Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA1c and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies
    David Nathanson, Katarina Eeg‐Olofsson, Tim D. Spelman, Erik Bülow, Mattias Kyhlstedt, Fleur Levrat‐Guillen, Jan Bolinder · 2024 · Diabetologia
  40. Dysglycemia in adults at risk for or living with non-insulin treated type 2 diabetes: Insights from continuous glucose monitoring
    Souptik Barua, Ashutosh Sabharwal, NAMINO M. GLANTZ, Casey Conneely, ARIANNA J. LAREZ, Wendy C. Bevier, David E. Kerr · 2021 · EClinicalMedicine
  41. Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits
    MEGHAN E. PAULEY, Kalie L. Tommerdahl, Janet K. Snell‐Bergeon, Gregory P. Forlenza · 2022 · Current Cardiology Reports
  42. Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon?
    Vala Hamidi, Jeremy Pettus · 2024 · Diabetes Care
  43. Technological advances shaping diabetes care
    Halis Kaan Aktürk, Satish K. Garg · 2019 · Current Opinion in Endocrinology Diabetes and Obesity
  44. Analysis of Retinal Perfusion in Children, Adolescents, and Young Adults with Type 1 Diabetes Using Optical Coherence Tomography Angiography
    Chiara Mameli, Alessandro Invernizzi, Alice Bolchini, Giorgio Bedogni, Elisa Giani, Maddalena Macedoni, Gianvincenzo Zuccotti, Chiara Preziosa, Marco Pellegrini · 2019 · Journal of Diabetes Research
  45. Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries?
    Luís Eduardo Calliari, Márcio Krakauer, André Gustavo Daher Vianna, Yashesvini Ram, Douglas Eugenio Barbieri, Yongjin Xu, Timothy C. Dunn · 2020 · Diabetology & Metabolic Syndrome
  46. Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel
    Sanjay Kalra, Shehla Sajid Shaikh, Gagan Priya, ManasP Baruah, Abhyudaya Verma, Ashok Kumar Das, Mona Shah, Sambit Das, Deepak Khandelwal, Debmalya Sanyal et al. · 2020 · Diabetes Therapy
  47. Prediction of Incident Diabetic Retinopathy in Adults With Type 1 Diabetes Using Machine Learning Approach: An Exploratory Study
    Eslam Montaser, Viral N. Shah · 2024 · Journal of Diabetes Science and Technology
  48. Acceptability of Continuous Glucose Monitoring in Elderly Diabetes Patients Using Multiple Daily Insulin Injections
    Špela Volčanšek, Mojca Lunder, Andrej Janež · 2019 · Diabetes Technology & Therapeutics
  49. Impact of Fast-Acting Insulin Aspart on Glycemic Control in Patients with Type 1 Diabetes Using Intermittent-Scanning Continuous Glucose Monitoring Within a Real-World Setting: The GoBolus Study
    Thomas Danne, Matthias Axel Schweitzer, Winfried Keuthage, Stefan Kipper, Y Kretzschmar, Jörg Simon, Tanja Wiedenmann, Ralph Ziegler · 2020 · Diabetes Technology & Therapeutics
  50. The Correlation between Time in Range and Diabetic Microvascular Complications Utilizing Information Management Platform
    Xia Sheng, Guohui Xiong, Pengfei Yu, Jian-Ping Liu · 2020 · International Journal of Endocrinology
  51. Current concepts and clinical importance of glycemic variability
    Ramya Ravi, Viswanathan Balasubramaniam, Gowthamarajan Kuppusamy, Sivasankaran Ponnusankar · 2021 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
  52. Clinical Application of Time in Range and Other Metrics
    Grazia Aleppo · 2021 · Diabetes Spectrum
  53. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2
    Christoph Nowak, Marcus Lind, Zdenĕk Šumnı́k, Terezie Pelikánová, Lía Nattero‐Chávez, Elena Lundberg, Itxaso Rica, Maria Asunción Martínez‐Brocca, Marisol Ruiz de Adana, Jeanette Wahlberg et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  54. Insulin resistance is associated with the presence and severity of retinopathy in patients with type 2 diabetes
    Yuxin Xu, Shengdan Pu, Yi‐Tong Zhang, Xue‐Wei Tong, Xiao‐Tong Sun, Yongyan Shan, Xin‐Yuan Gao · 2023 · Clinical and Experimental Ophthalmology
  55. Effectiveness of continuous glucose monitoring in patient management of Type 2 Diabetes Mellitus: an umbrella review of systematic reviews from 2011 to 2024
    Yong Yi Tan, Enhui Suan, Gerald Choon‐Huat Koh, Suhana Binte Suhairi, Shilpa Tyagi · 2024 · Archives of Public Health
  56. Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial – study protocol
    Kaat Beunen, Nancy Van Wilder, Dominique Ballaux, Gerd Vanhaverbeke, Youri Taes, Xavier-Philippe Aers, Frank R. E. Nobels, Joke Marlier, Da Young Lee, Joke Cuypers et al. · 2023 · BMC Pregnancy and Childbirth
  57. Precision Dosing of Rapid-Acting Insulin Matters
    Henk‐Jan Aanstoot, Henry Rodriguez, STUART ALAN WEINZIMER, Nan Vint, Lisette Koeneman · 2020 · Diabetes Technology & Therapeutics
  58. Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
    Rodrigo Ribeiro e Silva, Mateus de Miranda Gauza, Maria Eduarda Schramm Guisso, Júlia Opolski Nunes da Silva, Suely Keiko Kohara · 2023 · Archives of Endocrinology and Metabolism
  59. Multimodal digital phenotyping of diet, physical activity, and glycemia in Hispanic/Latino adults with or at risk of type 2 diabetes
    Amruta Pai, Rony Santiago, NAMINO M. GLANTZ, Wendy C. Bevier, Souptik Barua, Ashutosh Sabharwal, David E. Kerr · 2024 · npj Digital Medicine
  60. HbA1c
    Anders L. Carlson, Amy B. Criego, Thomas W. Martens, Richard M. Bergenstal · 2019 · Endocrinology and Metabolism Clinics of North America
  61. Benefits and limitations of continuous glucose monitoring in type 1 diabetes
    Stone, Jenine Y, Bailey, Timothy S · 2020 · Expert Review of Endocrinology & Metabolism
  62. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes
    Antonio Cutruzzolà, Concetta Irace, Martina Parise, Raffaella Fiorentino, Pier Francesco Pio Tripodi, Serena Ungaro, Valerie N. Babinsky, Agostino Gnasso · 2020 · Nutrition Metabolism and Cardiovascular Diseases
  63. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes
    Naru Babaya, Shinsuke Noso, Yoshihisa Hiromine, Yasunori Taketomo, Fumimaru Niwano, Sawa Yoshida, Sara Yasutake, Yumiko Kawabata, Hiroshi Ikegami · 2021 · Scientific Reports
  64. Profiles of Intraday Glucose in Type 2 Diabetes and Their Association with Complications: An Analysis of Continuous Glucose Monitoring Data
    Jithin Sam Varghese, Joyce C. Ho, Ranjit Mohan Anjana, Rajendra Pradeepa, Shivani Anil Patel, Saravanan Jebarani, Viswanathan Baskar, K.M. Venkat Narayan, Viswanathan Mohan · 2021 · Diabetes Technology & Therapeutics
  65. The automated pancreas: A review of technologies and clinical practice
    Torben Biester, Martin Tauschmann, Agata P Chobot, Olga Kordonouri, Thomas Danne, Thomas Michael Kapellen, Klemen Dovč · 2021 · Diabetes Obesity and Metabolism
  66. Updated Recommendations on Cardiovascular Prevention in 2022: An Executive Document of the Italian Society of Cardiovascular Prevention
    Massimo Volpe, Giovanna Gallo, Maria Grazia Modena, Claudio Ferri, Giovambattista Desideri, Giuliano Tocci, Members of the Board of the Italian Society of Cardiovascular Prevention, Simonetta Bellone, Marco Bertolotti, Alessandro Biffi et al. · 2022 · High Blood Pressure & Cardiovascular Prevention
  67. Open source automated insulin delivery: addressing the challenge
    Nick S. Oliver, Monika Reddy, Claire Marriott, Tomas C. Walker, Lutz Heinemann · 2019 · npj Digital Medicine
  68. Enhanced structure and function of human pluripotent stem cell-derived beta-cells cultured on extracellular matrix
    Reena Singh, Louise Cottle, Thomas Loudovaris, Di Xiao, Pengyi Yang, Helen E. Thomas, Melkam Alamerew Kebede, Peter Thorn · 2020 · Stem Cells Translational Medicine
  69. Cost-effectiveness of a novel hybrid closed-loop system compared with continuous subcutaneous insulin infusion in people with type 1 diabetes in the UK
    Stéphane Roze, Maria Ida Buompensiere, Zeynep Ozdemir, Simona de Portu, Ohad Cohen · 2021 · Journal of Medical Economics
  70. Glycemic control during Ramadan fasting in adolescents and young adults with type 1 diabetes on MiniMed™ 780G advanced hybrid closed‑loop system: A randomized controlled trial
    Nancy Samir Elbarbary, Eman Abdel Rahman Ismail · 2022 · Diabetes Research and Clinical Practice
  71. Distributional data analysis of accelerometer data from the NHANES database using nonparametric survey regression models
    Marcos Matabuena, Alexander Petersen · 2023 · Journal of the Royal Statistical Society Series C (Applied Statistics)
  72. Early Real-World Performance of the MiniMed™ 780G Advanced Hybrid Closed-Loop System and Recommended Settings Use in the United States
    James R. Thrasher, Arcelia Arrieta, Fang Niu, Katherine R. Cameron, Toni L. Cordero, John Shin, Andrew S. Rhinehart, Robert Alan Vigersky · 2024 · Diabetes Technology & Therapeutics
  73. Heterogeneity of glycaemic phenotypes in type 1 diabetes
    Guy Fagherazzi, Gloria Aguayo, Lu Zhang, Hélène P. Hanaire, Sylvie Picard, Laura Sablone, Bruno L Vergès, Naïma Hamamouche, B. Detournay, Michaël Joubert et al. · 2024 · Diabetologia
  74. Continuous Glucose Monitoring–Derived Data Report—Simply a Better Management Tool
    Tadej Battelino, Richard M. Bergenstal · 2020 · Diabetes Care
  75. Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus
    PHILIP A. LEVIN, Byron J. Hoogwerf, Janet K. Snell‐Bergeon, Tim Vigers, Laura L. Pyle, Lee A. Bromberger · 2020 · Endocrine Practice
  76. Biosensing Technologies for Chronic Diseases
    Min Park, Yun Jung Heo · 2021 · BioChip Journal
  77. Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?
    Christopher Martin, Amy B. Criego, Anders L. Carlson, Richard M. Bergenstal · 2019 · Current Diabetes Reports
  78. Stepwise approach to continuous glucose monitoring interpretation for internists and family physicians
    Szmuilowicz, Emily D., Aleppo, Grazia · 2022 · Postgraduate Medicine
  79. Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes
    Julia C. Prentice, David C. Mohr, Libin Zhang, Donglin Li, Aaron Legler, Richard E. Nelson, Paul R. Conlin · 2021 · Diabetes Care
  80. The clinical utility of professional continuous glucose monitoring by pharmacists for patients with type 2 diabetes
    Heather Ulrich, Monica M. Bowen · 2021 · Journal of the American Pharmacists Association
  81. Association between glycaemia risk index ( GRI ) and diabetic retinopathy in type 2 diabetes: A cohort study
    Yaxin Wang, Jingyi Lu, Jiaying Ni, Ming Wang, Yun Shen, Wei Lu, Wei Zhu, Yuqian Bao, David Rodbard, Robert Alan Vigersky et al. · 2023 · Diabetes Obesity and Metabolism
  82. Diabetic peripheral neuropathy and glycemic variability assessed by continuous glucose monitoring: A systematic review and meta-analysis
    Yifan Jia, Dan Long, Yunshuang Yang, Qiong Wang, Qunli Wu, Qian Zhang · 2024 · Diabetes Research and Clinical Practice
  83. Effect of CPAP on blood glucose fluctuation in patients with type 2 diabetes mellitus and obstructive sleep apnea
    Xin Zhao, Wei Zhang, Sixu Xin, Xiaofeng Yu, Xiaomei Zhang · 2022 · Sleep And Breathing
  84. Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems
    Halis Kaan Aktürk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim R. A. van den Heuvel, Ohad Cohen · 2024 · Diabetes Technology & Therapeutics
  85. Association Between Continuous Glucose Monitoring-Derived Glycemia Risk Index and Albuminuria in Type 2 Diabetes
    Jee Hee Yoo, Ji Yoon Kim, Jae Hyeon Kim · 2023 · Diabetes Technology & Therapeutics
  86. Critical Reappraisal of the Time-in-Range: Alternative or Useful Addition to Glycated Hemoglobin?
    Lutz Heinemann, Guido Freckmann, Dirk Müller‐Wieland, Monika Kellerer · 2019 · Journal of Diabetes Science and Technology
  87. Continuous glucose monitoring versus self-monitoring of blood glucose in the management of cystic fibrosis related diabetes: a systematic review and meta-analysis
    Kumar, Shanal, Soldatos, Georgia, Ranasinha, Sanjeeva, Teede, Helena, Pallin, Michael · 2023 · Journal of Cystic Fibrosis
  88. Beyond HbA<sub>1c</sub>: using continuous glucose monitoring metrics to enhance interpretation of treatment effect and improve clinical decision‐making
    Brown, S. A., Basu, A., Kovatchev, B. P. · 2019 · Diabetic Medicine
  89. Continuous glucose monitoring defined time-in-range is associated with sudomotor dysfunction in type 2 diabetes
    Qingyu Guo, Bin Lu, Zhanhong Guo, Zhouqin Feng, Yanyu Yuan, Xuguang Jin, Pu Zang, Ping Gu, Jiaqing Shao · 2020 · World Journal of Diabetes
  90. Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics
    Paloma Pérez-López, Pablo Fernández-Velasco, Pilar Bahillo-Curieses, Daniel Antonio de Luis, Gonzalo Díaz-Soto · 2023 · Endocrine
  91. Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial
    Nadine Taleb, André C. Carpentier, Virginie Messier, Martin Ladouceur, Ahmad Haidar, RÉMI P.R. RABASA-LHORET · 2019 · Diabetes Care
  92. A clinical review of the t:slim X2 insulin pump
    Cari Berget, Samantha Louise Lange, Laurel H. Messer, Gregory P. Forlenza · 2020 · Expert Opinion on Drug Delivery
  93. Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial
    André Gustavo Daher Vianna, Claudio Silva de Lacerda, Luciana Muniz Pechmann, Michelle Garcia Polesel, Emerson Cestari Marino, Mauro Scharf, Josiane M. Detsch, Kleber Marques, Claudia P. Sanches · 2019 · Diabetes Obesity and Metabolism
  94. Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
    Seung Min Chung, Yun Hee Lee, Chang Oh Kim, Ji Yeon Lee, Sang‐Man Jin, Seung-Hyun Yoo, Jun Sung Moon, Kwang Joon Kim · 2021 · Journal of Korean Medical Science
  95. Comparison of glucose time in range and area under curve in range in relation to risk of diabetic retinopathy in type 2 diabetes patients
    Yaxin Wang, Jingyi Lu, Yun Shen, Jiaying Ni, Lei Zhang, Wei Lu, Wei Zhu, Yuqian Bao, Jian Zhou · 2022 · Journal of Diabetes Investigation
  96. Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study
    Michael Anthony Rotondi, Octavia C. Y. Wong, Michael Charles Riddell, Bruce A. Perkins · 2022 · Diabetes Care
  97. Assessing the feasibility of time in tight range (TITR) targets with advanced hybrid closed loop (AHCL) use in children and adolescents: A single‐centre real‐world study
    Elif Eviz, Nesrin Ecem Kıllı, Kagan Ege Karakus, Ecem Can, Tuğba Gökçe, Gül Yeşiltepe Mutlu, Şükrü Hatun · 2024 · Diabetic Medicine
  98. The Effect of Acarbose on Glycemic Variability in Patients with Type 2 Diabetes Mellitus Using Premixed Insulin Compared to Metformin (AIM): An Open-Label Randomized Trial
    Fei Gao, Xiaojing Ma, Jiahui Peng, Jingyi Lu, Wei Lu, Wei Zhu, Yuqian Bao, Robert Alan Vigersky, Weiping Jia, Jian Zhou · 2019 · Diabetes Technology & Therapeutics
  99. Associations of Time in Range and Other Continuous Glucose Monitoring–Derived Metrics With Well-Being and Patient-Reported Outcomes: Overview and Trends
    Dominic Ehrmann, Lilli Priesterroth, ANDREAS J. SCHMITT, Bernhard Kulzer, Norbert Hermanns · 2021 · Diabetes Spectrum
  100. Time in range—A new gold standard in type 2 diabetes research?
    Ashni Goshrani, Rose Lin, David Norman O'Neal, Elif Ilhan Ekinci · 2025 · Diabetes Obesity and Metabolism